 | • レポートコード：MRC2-11QY03838 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は感染症検査における分子診断のグローバル市場について調査・分析したレポートです。種類別（ポリメラーゼ連鎖反応（PCR）、等温核酸増幅技術（INAAT）、マイクロアレイ、次世代シーケンシング（NGS）、ハイブリダイゼーション、その他）市場規模、用途別（病院、診療所、学術機関、研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別感染症検査における分子診断の競争状況、市場シェア ・世界の感染症検査における分子診断市場：種類別市場規模 2015年-2020年（ポリメラーゼ連鎖反応（PCR）、等温核酸増幅技術（INAAT）、マイクロアレイ、次世代シーケンシング（NGS）、ハイブリダイゼーション、その他） ・世界の感染症検査における分子診断市場：種類別市場規模予測 2021年-2026年（ポリメラーゼ連鎖反応（PCR）、等温核酸増幅技術（INAAT）、マイクロアレイ、次世代シーケンシング（NGS）、ハイブリダイゼーション、その他） ・世界の感染症検査における分子診断市場：用途別市場規模 2015年-2020年（病院、診療所、学術機関、研究所、その他） ・世界の感染症検査における分子診断市場：用途別市場規模予測 2021年-2026年（病院、診療所、学術機関、研究所、その他） ・北米の感染症検査における分子診断市場分析：米国、カナダ ・ヨーロッパの感染症検査における分子診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの感染症検査における分子診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の感染症検査における分子診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの感染症検査における分子診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、BD、BioMerieux、Thermo Fisher Scientific、Roche、Siemens、Veridex、Luminex、GenMark Diagnostics、Qiagen、Genomix Biotech、BioTheranostics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others. Increasing number of infectious diseases and technological advancement in diagnostic technologies for infectious diseases are some major driving factors for molecular diagnostics in the infectious disease testing market. Molecular diagnostics technologies are mainly used to diagnose diseases such as AIDS, tuberculosis (TB), hepatitis, and hospital-acquired infections.
North America has the largest market for molecular diagnostics in infectious disease testing, followed by Europe. This is due to technological advancement in molecular diagnostic tools, increasing prevalence of infectious diseases and improved healthcare infrastructure in the region. The market in Asia too, is expected to witness a high growth rate in the next few years. This is due to evolving research and development activities on infectious diseases, increasing government support, growing awareness among people about various infectious diseases and their diagnostic procedures, and improving healthcare infrastructure in the region. In addition, growing population and economies in developing countries, such as India and China, are expected to influence the growth in molecular diagnostics in infectious disease testing in Asia.
Market Analysis and Insights: Global Molecular Diagnostics in Infectious Disease Testing Market
The global Molecular Diagnostics in Infectious Disease Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Molecular Diagnostics in Infectious Disease Testing Scope and Market Size
Molecular Diagnostics in Infectious Disease Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics in Infectious Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott
BD
BioMerieux
Thermo Fisher Scientific
Roche
Siemens
Veridex
Luminex
GenMark Diagnostics
Qiagen
Genomix Biotech
BioTheranostics
Market segment by Type, the product can be split into
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Microarrays
Next-Generation Sequencing (NGS)
Hybridization
Others
Market segment by Application, split into
Hospitals
Clinics
Academic Institutes
Laboratories
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Molecular Diagnostics in Infectious Disease Testing Revenue
1.4 Market by Type
1.4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Polymerase Chain Reaction (PCR)
1.4.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.4.4 Microarrays
1.4.5 Next-Generation Sequencing (NGS)
1.4.6 Hybridization
1.4.7 Others
1.5 Market by Application
1.5.1 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Academic Institutes
1.5.5 Laboratories
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Perspective (2015-2026)
2.2 Global Molecular Diagnostics in Infectious Disease Testing Growth Trends by Regions
2.2.1 Molecular Diagnostics in Infectious Disease Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Molecular Diagnostics in Infectious Disease Testing Historic Market Share by Regions (2015-2020)
2.2.3 Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Molecular Diagnostics in Infectious Disease Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Molecular Diagnostics in Infectious Disease Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Market Size
3.1.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Revenue (2015-2020)
3.1.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio
3.2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics in Infectious Disease Testing Revenue in 2019
3.3 Molecular Diagnostics in Infectious Disease Testing Key Players Head office and Area Served
3.4 Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
3.5 Date of Enter into Molecular Diagnostics in Infectious Disease Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Type (2015-2020)
4.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020)
5.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size (2015-2020)
6.2 Molecular Diagnostics in Infectious Disease Testing Key Players in North America (2019-2020)
6.3 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020)
6.4 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size (2015-2020)
7.2 Molecular Diagnostics in Infectious Disease Testing Key Players in Europe (2019-2020)
7.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020)
7.4 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020)
8 China
8.1 China Molecular Diagnostics in Infectious Disease Testing Market Size (2015-2020)
8.2 Molecular Diagnostics in Infectious Disease Testing Key Players in China (2019-2020)
8.3 China Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020)
8.4 China Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Molecular Diagnostics in Infectious Disease Testing Market Size (2015-2020)
9.2 Molecular Diagnostics in Infectious Disease Testing Key Players in Japan (2019-2020)
9.3 Japan Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020)
9.4 Japan Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size (2015-2020)
10.2 Molecular Diagnostics in Infectious Disease Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020)
11 India
11.1 India Molecular Diagnostics in Infectious Disease Testing Market Size (2015-2020)
11.2 Molecular Diagnostics in Infectious Disease Testing Key Players in India (2019-2020)
11.3 India Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020)
11.4 India Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Molecular Diagnostics in Infectious Disease Testing Market Size (2015-2020)
12.2 Molecular Diagnostics in Infectious Disease Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020)
12.4 Central & South America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Introduction
13.1.4 Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 BD
13.2.1 BD Company Details
13.2.2 BD Business Overview
13.2.3 BD Molecular Diagnostics in Infectious Disease Testing Introduction
13.2.4 BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
13.2.5 BD Recent Development
13.3 BioMerieux
13.3.1 BioMerieux Company Details
13.3.2 BioMerieux Business Overview
13.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Introduction
13.3.4 BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
13.3.5 BioMerieux Recent Development
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Details
13.4.2 Thermo Fisher Scientific Business Overview
13.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Introduction
13.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
13.4.5 Thermo Fisher Scientific Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview
13.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Introduction
13.5.4 Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
13.5.5 Roche Recent Development
13.6 Siemens
13.6.1 Siemens Company Details
13.6.2 Siemens Business Overview
13.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Introduction
13.6.4 Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
13.6.5 Siemens Recent Development
13.7 Veridex
13.7.1 Veridex Company Details
13.7.2 Veridex Business Overview
13.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Introduction
13.7.4 Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
13.7.5 Veridex Recent Development
13.8 Luminex
13.8.1 Luminex Company Details
13.8.2 Luminex Business Overview
13.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Introduction
13.8.4 Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
13.8.5 Luminex Recent Development
13.9 GenMark Diagnostics
13.9.1 GenMark Diagnostics Company Details
13.9.2 GenMark Diagnostics Business Overview
13.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Introduction
13.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
13.9.5 GenMark Diagnostics Recent Development
13.10 Qiagen
13.10.1 Qiagen Company Details
13.10.2 Qiagen Business Overview
13.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Introduction
13.10.4 Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
13.10.5 Qiagen Recent Development
13.11 Genomix Biotech
10.11.1 Genomix Biotech Company Details
10.11.2 Genomix Biotech Business Overview
10.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Introduction
10.11.4 Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
10.11.5 Genomix Biotech Recent Development
13.12 BioTheranostics
10.12.1 BioTheranostics Company Details
10.12.2 BioTheranostics Business Overview
10.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Introduction
10.12.4 BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
10.12.5 BioTheranostics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Molecular Diagnostics in Infectious Disease Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Molecular Diagnostics in Infectious Disease Testing Revenue
Table 3. Ranking of Global Top Molecular Diagnostics in Infectious Disease Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Polymerase Chain Reaction (PCR)
Table 6. Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT)
Table 7. Key Players of Microarrays
Table 8. Key Players of Next-Generation Sequencing (NGS)
Table 9. Key Players of Hybridization
Table 10. Key Players of Others
Table 11. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Regions (2015-2020)
Table 15. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Molecular Diagnostics in Infectious Disease Testing Market Growth Strategy
Table 21. Main Points Interviewed from Key Molecular Diagnostics in Infectious Disease Testing Players
Table 22. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Players (2015-2020) (Million US$)
Table 23. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players (2015-2020)
Table 24. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2019)
Table 25. Global Molecular Diagnostics in Infectious Disease Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
Table 28. Date of Enter into Molecular Diagnostics in Infectious Disease Testing Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 31. Global Molecular Diagnostics in Infectious Disease Testing Market Size Share by Type (2015-2020)
Table 32. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2021-2026)
Table 33. Global Molecular Diagnostics in Infectious Disease Testing Market Size Share by Application (2015-2020)
Table 34. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 35. Global Molecular Diagnostics in Infectious Disease Testing Market Size Share by Application (2021-2026)
Table 36. North America Key Players Molecular Diagnostics in Infectious Disease Testing Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Molecular Diagnostics in Infectious Disease Testing Market Share (2019-2020)
Table 38. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 39. North America Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2015-2020)
Table 40. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 41. North America Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2015-2020)
Table 42. Europe Key Players Molecular Diagnostics in Infectious Disease Testing Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Molecular Diagnostics in Infectious Disease Testing Market Share (2019-2020)
Table 44. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2015-2020)
Table 46. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2015-2020)
Table 48. China Key Players Molecular Diagnostics in Infectious Disease Testing Revenue (2019-2020) (Million US$)
Table 49. China Key Players Molecular Diagnostics in Infectious Disease Testing Market Share (2019-2020)
Table 50. China Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 51. China Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2015-2020)
Table 52. China Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 53. China Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2015-2020)
Table 54. Japan Key Players Molecular Diagnostics in Infectious Disease Testing Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Molecular Diagnostics in Infectious Disease Testing Market Share (2019-2020)
Table 56. Japan Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2015-2020)
Table 58. Japan Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Molecular Diagnostics in Infectious Disease Testing Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Molecular Diagnostics in Infectious Disease Testing Market Share (2019-2020)
Table 62. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2015-2020)
Table 64. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2015-2020)
Table 66. India Key Players Molecular Diagnostics in Infectious Disease Testing Revenue (2019-2020) (Million US$)
Table 67. India Key Players Molecular Diagnostics in Infectious Disease Testing Market Share (2019-2020)
Table 68. India Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 69. India Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2015-2020)
Table 70. India Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 71. India Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Molecular Diagnostics in Infectious Disease Testing Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Molecular Diagnostics in Infectious Disease Testing Market Share (2019-2020)
Table 74. Central & South America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2015-2020)
Table 76. Central & South America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2015-2020)
Table 78. Abbott Company Details
Table 79. Abbott Business Overview
Table 80. Abbott Product
Table 81. Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 82. Abbott Recent Development
Table 83. BD Company Details
Table 84. BD Business Overview
Table 85. BD Product
Table 86. BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 87. BD Recent Development
Table 88. BioMerieux Company Details
Table 89. BioMerieux Business Overview
Table 90. BioMerieux Product
Table 91. BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 92. BioMerieux Recent Development
Table 93. Thermo Fisher Scientific Company Details
Table 94. Thermo Fisher Scientific Business Overview
Table 95. Thermo Fisher Scientific Product
Table 96. Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 97. Thermo Fisher Scientific Recent Development
Table 98. Roche Company Details
Table 99. Roche Business Overview
Table 100. Roche Product
Table 101. Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 102. Roche Recent Development
Table 103. Siemens Company Details
Table 104. Siemens Business Overview
Table 105. Siemens Product
Table 106. Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 107. Siemens Recent Development
Table 108. Veridex Company Details
Table 109. Veridex Business Overview
Table 110. Veridex Product
Table 111. Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 112. Veridex Recent Development
Table 113. Luminex Business Overview
Table 114. Luminex Product
Table 115. Luminex Company Details
Table 116. Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 117. Luminex Recent Development
Table 118. GenMark Diagnostics Company Details
Table 119. GenMark Diagnostics Business Overview
Table 120. GenMark Diagnostics Product
Table 121. GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 122. GenMark Diagnostics Recent Development
Table 123. Qiagen Company Details
Table 124. Qiagen Business Overview
Table 125. Qiagen Product
Table 126. Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 127. Qiagen Recent Development
Table 128. Genomix Biotech Company Details
Table 129. Genomix Biotech Business Overview
Table 130. Genomix Biotech Product
Table 131. Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 132. Genomix Biotech Recent Development
Table 133. BioTheranostics Company Details
Table 134. BioTheranostics Business Overview
Table 135. BioTheranostics Product
Table 136. BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 137. BioTheranostics Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Type: 2020 VS 2026
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Isothermal Nucleic Acid Amplification Technology (INAAT) Features
Figure 4. Microarrays Features
Figure 5. Next-Generation Sequencing (NGS) Features
Figure 6. Hybridization Features
Figure 7. Others Features
Figure 8. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application: 2020 VS 2026
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Academic Institutes Case Studies
Figure 12. Laboratories Case Studies
Figure 13. Others Case Studies
Figure 14. Molecular Diagnostics in Infectious Disease Testing Report Years Considered
Figure 15. Global Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Regions: 2020 VS 2026
Figure 17. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players in 2019
Figure 20. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue in 2019
Figure 22. North America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed
感染症診断検査の世界市場（～2026年） Market Analysis and Insights: Global Infectious Disease Diagnostic Testing Market The global Infectious Disease Diagnostic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Infectious Disease Diagnostic Testing S…- 感染症検査の世界市場（～2026年） In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection. Biochemical tests used in th…
- 核酸増幅検査の世界市場（～2026年） Market Analysis and Insights: Global Nucleic Acid Amplification Testing Market The global Nucleic Acid Amplification Testing market size is projected to reach US$ 137.6 million by 2026, from US$ 131.5 million in 2020, at a CAGR of 4.3%% during 2021-2026. Global Nucleic Acid Amplification Testing Sco…
- IVD感染症の世界市場（～2026年） In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.). Geographically, North America is the world's largest extracorporeal diagnostic market. Europe and the United S…
- ポイントオブケア感染症診断の世界市場（～2026年） Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment. The point-of-care infectious disease diagnostics market is expected to register a fast growth over the forecast period owing to the emerging trend of patient-centric se…